| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retina | 21 | 2022 | 86 | 4.820 |
Why?
|
| Endothelial Cells | 7 | 2022 | 203 | 3.110 |
Why?
|
| Microglia | 7 | 2022 | 66 | 2.770 |
Why?
|
| Receptors, CXCR5 | 5 | 2020 | 5 | 2.580 |
Why?
|
| Macular Degeneration | 4 | 2021 | 27 | 2.330 |
Why?
|
| Diabetic Retinopathy | 7 | 2020 | 72 | 2.190 |
Why?
|
| Retinal Degeneration | 4 | 2020 | 22 | 1.900 |
Why?
|
| Retinal Vessels | 6 | 2020 | 27 | 1.890 |
Why?
|
| Antioxidants | 3 | 2020 | 126 | 1.700 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 1118 | 1.700 |
Why?
|
| Inflammation | 9 | 2022 | 557 | 1.660 |
Why?
|
| Retinal Pigment Epithelium | 5 | 2021 | 25 | 1.630 |
Why?
|
| Pericytes | 3 | 2022 | 32 | 1.500 |
Why?
|
| Signal Transduction | 7 | 2020 | 765 | 1.390 |
Why?
|
| Drug Discovery | 3 | 2020 | 38 | 1.370 |
Why?
|
| Animals | 34 | 2022 | 8544 | 1.350 |
Why?
|
| Choroidal Neovascularization | 6 | 2021 | 9 | 1.340 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2022 | 118 | 1.340 |
Why?
|
| Blood-Retinal Barrier | 4 | 2020 | 5 | 1.260 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2020 | 4 | 1.250 |
Why?
|
| Mice | 19 | 2022 | 2691 | 1.200 |
Why?
|
| Mice, Knockout | 8 | 2020 | 484 | 1.120 |
Why?
|
| Mice, Inbred C57BL | 12 | 2022 | 834 | 1.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2019 | 227 | 0.990 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2019 | 10 | 0.910 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2019 | 25 | 0.910 |
Why?
|
| Zebrafish | 2 | 2021 | 24 | 0.850 |
Why?
|
| NF-kappa B | 2 | 2021 | 88 | 0.810 |
Why?
|
| Apoptosis | 8 | 2020 | 400 | 0.790 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2022 | 7 | 0.770 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 18 | 0.750 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2020 | 12 | 0.740 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 84 | 0.720 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 104 | 0.710 |
Why?
|
| Microvessels | 1 | 2020 | 31 | 0.650 |
Why?
|
| Receptors, Chemokine | 2 | 2022 | 11 | 0.640 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 67 | 0.640 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2020 | 1 | 0.640 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 3 | 0.640 |
Why?
|
| Calcium Channel Blockers | 1 | 2020 | 54 | 0.630 |
Why?
|
| Calcium Channels, L-Type | 1 | 2020 | 46 | 0.630 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 13 | 0.610 |
Why?
|
| Autoimmunity | 1 | 2019 | 34 | 0.600 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 20 | 0.600 |
Why?
|
| Proteomics | 2 | 2018 | 106 | 0.570 |
Why?
|
| Retinal Neovascularization | 3 | 2011 | 6 | 0.520 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2008 | 73 | 0.510 |
Why?
|
| Humans | 21 | 2022 | 34474 | 0.490 |
Why?
|
| Gene Expression Profiling | 7 | 2021 | 341 | 0.490 |
Why?
|
| Adaptation, Ocular | 3 | 2005 | 4 | 0.490 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 1078 | 0.450 |
Why?
|
| Cells, Cultured | 5 | 2020 | 887 | 0.440 |
Why?
|
| Pregnancy Proteins | 1 | 2014 | 14 | 0.430 |
Why?
|
| Leukostasis | 2 | 2011 | 3 | 0.420 |
Why?
|
| Blotting, Western | 6 | 2020 | 328 | 0.400 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2011 | 3 | 0.360 |
Why?
|
| Macrophages | 1 | 2013 | 216 | 0.360 |
Why?
|
| Glucose | 3 | 2022 | 194 | 0.350 |
Why?
|
| Capillary Permeability | 4 | 2011 | 18 | 0.350 |
Why?
|
| Eye | 1 | 2011 | 16 | 0.340 |
Why?
|
| Retinal Neurons | 1 | 2011 | 4 | 0.340 |
Why?
|
| Blood Vessels | 1 | 2011 | 60 | 0.340 |
Why?
|
| Corneal Neovascularization | 1 | 2010 | 1 | 0.330 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 2 | 0.330 |
Why?
|
| Retinal Diseases | 3 | 2020 | 26 | 0.330 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 15 | 0.330 |
Why?
|
| Keratitis | 1 | 2010 | 4 | 0.330 |
Why?
|
| Pentose Phosphate Pathway | 2 | 2020 | 4 | 0.320 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 526 | 0.320 |
Why?
|
| Catalytic Domain | 2 | 2020 | 69 | 0.310 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 16 | 0.310 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2020 | 73 | 0.300 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 45 | 0.300 |
Why?
|
| Light | 3 | 2005 | 41 | 0.290 |
Why?
|
| Photoreceptor Cells | 3 | 2017 | 4 | 0.270 |
Why?
|
| Cadherins | 2 | 2020 | 30 | 0.270 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 70 | 0.260 |
Why?
|
| Peptide Fragments | 1 | 2010 | 429 | 0.260 |
Why?
|
| Rats | 4 | 2022 | 1946 | 0.250 |
Why?
|
| Phenotype | 2 | 2020 | 656 | 0.250 |
Why?
|
| Up-Regulation | 3 | 2019 | 202 | 0.250 |
Why?
|
| Caspase 3 | 2 | 2020 | 43 | 0.250 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2011 | 17 | 0.240 |
Why?
|
| Ligands | 2 | 2019 | 97 | 0.240 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2020 | 8 | 0.230 |
Why?
|
| Reperfusion Injury | 2 | 2019 | 58 | 0.230 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 98 | 0.230 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 3 | 0.220 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2004 | 5 | 0.220 |
Why?
|
| Female | 7 | 2022 | 21490 | 0.200 |
Why?
|
| Chemokine CXCL13 | 2 | 2020 | 4 | 0.200 |
Why?
|
| Computational Biology | 2 | 2019 | 100 | 0.200 |
Why?
|
| Proteins | 1 | 2004 | 155 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 27 | 0.200 |
Why?
|
| Angiopoietins | 1 | 2022 | 2 | 0.190 |
Why?
|
| Eye Burns | 1 | 2022 | 3 | 0.190 |
Why?
|
| Burns, Chemical | 1 | 2022 | 8 | 0.190 |
Why?
|
| Male | 8 | 2020 | 20697 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 2 | 2020 | 118 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 49 | 0.190 |
Why?
|
| Coculture Techniques | 1 | 2022 | 86 | 0.190 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 38 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 281 | 0.190 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 122 | 0.180 |
Why?
|
| Lasers | 3 | 2021 | 25 | 0.180 |
Why?
|
| Rabbits | 2 | 2021 | 231 | 0.180 |
Why?
|
| Data Mining | 1 | 2021 | 14 | 0.170 |
Why?
|
| Phylogeny | 1 | 2021 | 68 | 0.170 |
Why?
|
| Neuroglia | 1 | 2021 | 32 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 165 | 0.170 |
Why?
|
| Cell Line | 2 | 2019 | 476 | 0.160 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 2020 | 2 | 0.160 |
Why?
|
| Electroretinography | 1 | 2020 | 6 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2020 | 265 | 0.160 |
Why?
|
| Autophagy | 1 | 2020 | 56 | 0.160 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 4 | 0.160 |
Why?
|
| NADP | 1 | 2020 | 12 | 0.160 |
Why?
|
| Light Signal Transduction | 1 | 2020 | 1 | 0.160 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2020 | 4 | 0.160 |
Why?
|
| Exosomes | 1 | 2020 | 45 | 0.160 |
Why?
|
| Glutathione | 1 | 2020 | 54 | 0.160 |
Why?
|
| Models, Animal | 1 | 2020 | 198 | 0.160 |
Why?
|
| Glutathione Peroxidase | 1 | 2019 | 10 | 0.160 |
Why?
|
| Phospholipases A2 | 1 | 2019 | 25 | 0.160 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2019 | 1 | 0.150 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 47 | 0.150 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 38 | 0.150 |
Why?
|
| Binding, Competitive | 1 | 2019 | 44 | 0.150 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 51 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 103 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 23 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 282 | 0.150 |
Why?
|
| Databases, Genetic | 1 | 2019 | 40 | 0.150 |
Why?
|
| Chemokines | 1 | 2019 | 36 | 0.150 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 11 | 0.150 |
Why?
|
| Calreticulin | 1 | 2018 | 1 | 0.150 |
Why?
|
| Models, Molecular | 1 | 2019 | 207 | 0.140 |
Why?
|
| Protein Binding | 1 | 2019 | 255 | 0.140 |
Why?
|
| Drug Carriers | 1 | 2018 | 24 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 923 | 0.140 |
Why?
|
| In Situ Hybridization | 3 | 2008 | 48 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2019 | 250 | 0.140 |
Why?
|
| Animals, Newborn | 2 | 2011 | 143 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2018 | 57 | 0.140 |
Why?
|
| Peptides | 1 | 2018 | 142 | 0.130 |
Why?
|
| Mutation | 1 | 2020 | 529 | 0.130 |
Why?
|
| Melanosomes | 1 | 2017 | 1 | 0.130 |
Why?
|
| Lipofuscin | 1 | 2017 | 4 | 0.130 |
Why?
|
| Phagosomes | 1 | 2017 | 6 | 0.130 |
Why?
|
| Fundus Oculi | 1 | 2017 | 13 | 0.130 |
Why?
|
| cis-trans-Isomerases | 1 | 2017 | 34 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2019 | 924 | 0.120 |
Why?
|
| Corneal Stroma | 1 | 2016 | 6 | 0.120 |
Why?
|
| Blotting, Northern | 2 | 2008 | 35 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 44 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 45 | 0.120 |
Why?
|
| Gene Expression | 1 | 2016 | 362 | 0.110 |
Why?
|
| Capillaries | 1 | 2014 | 30 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 82 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2014 | 106 | 0.100 |
Why?
|
| Acetylglucosamine | 1 | 2014 | 6 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2022 | 545 | 0.100 |
Why?
|
| Oxygen | 2 | 2011 | 152 | 0.100 |
Why?
|
| Chick Embryo | 3 | 2008 | 76 | 0.100 |
Why?
|
| Circadian Rhythm | 2 | 2004 | 50 | 0.100 |
Why?
|
| Wet Macular Degeneration | 1 | 2013 | 3 | 0.100 |
Why?
|
| Ischemia | 2 | 2011 | 119 | 0.100 |
Why?
|
| Minocycline | 1 | 2013 | 12 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 51 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 44 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 270 | 0.100 |
Why?
|
| Cell Movement | 1 | 2013 | 180 | 0.090 |
Why?
|
| Body Weight | 1 | 2014 | 343 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2014 | 529 | 0.090 |
Why?
|
| Sweetening Agents | 1 | 2011 | 8 | 0.090 |
Why?
|
| Retinopathy of Prematurity | 1 | 2011 | 10 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2011 | 33 | 0.090 |
Why?
|
| Lectins | 1 | 2011 | 11 | 0.090 |
Why?
|
| Basement Membrane | 1 | 2011 | 10 | 0.090 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 15 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2011 | 15 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2011 | 6 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4150 | 0.090 |
Why?
|
| Actins | 1 | 2011 | 56 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2011 | 47 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 204 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 66 | 0.080 |
Why?
|
| Conjunctiva | 1 | 2010 | 5 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 163 | 0.080 |
Why?
|
| Aging | 1 | 2017 | 1010 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 71 | 0.080 |
Why?
|
| Cell Survival | 1 | 2011 | 304 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 260 | 0.080 |
Why?
|
| Genotype | 1 | 2011 | 743 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2011 | 730 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2008 | 484 | 0.070 |
Why?
|
| Aged | 2 | 2019 | 10998 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 1 | 2008 | 5 | 0.070 |
Why?
|
| Chickens | 1 | 2008 | 40 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2008 | 72 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2008 | 34 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2008 | 36 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2008 | 50 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2008 | 30 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 80 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 55 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 175 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2005 | 201 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 153 | 0.070 |
Why?
|
| Synapses | 1 | 2008 | 89 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2005 | 11 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 15 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 87 | 0.060 |
Why?
|
| Estradiol | 1 | 2005 | 156 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2005 | 148 | 0.050 |
Why?
|
| RNA, Transfer, Gly | 1 | 2004 | 1 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 3 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2004 | 2 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2004 | 5 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 85 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2004 | 143 | 0.050 |
Why?
|
| Rod Cell Outer Segment | 1 | 2003 | 1 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2005 | 192 | 0.050 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2003 | 38 | 0.050 |
Why?
|
| Alkalies | 1 | 2022 | 2 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cornea | 1 | 2022 | 19 | 0.050 |
Why?
|
| Chitin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2002 | 5 | 0.050 |
Why?
|
| Aspergillus | 1 | 2002 | 3 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2002 | 9 | 0.050 |
Why?
|
| Chromatography, Affinity | 1 | 2002 | 17 | 0.050 |
Why?
|
| Mitochondria | 1 | 2004 | 218 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2021 | 11 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 41 | 0.040 |
Why?
|
| Injections, Intraocular | 1 | 2018 | 2 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2018 | 18 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 40 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2018 | 146 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 319 | 0.030 |
Why?
|
| Aorta | 1 | 2018 | 139 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 21 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 63 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2016 | 208 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 22 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 7 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 56 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 84 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2014 | 88 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 174 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 4 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2011 | 3 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2011 | 10 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2011 | 11 | 0.020 |
Why?
|
| Fibronectins | 1 | 2011 | 40 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 24 | 0.020 |
Why?
|
| Dependovirus | 1 | 2011 | 20 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 52 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 72 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 127 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2008 | 5 | 0.020 |
Why?
|
| Organogenesis | 1 | 2008 | 18 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 40 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 152 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 129 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 593 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2005 | 128 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 117 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2003 | 9 | 0.010 |
Why?
|
| Animal Husbandry | 1 | 2003 | 8 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 10015 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 108 | 0.010 |
Why?
|
| Bromosuccinimide | 1 | 2002 | 1 | 0.010 |
Why?
|
| Reticulocytes | 1 | 2002 | 2 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 7 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2002 | 17 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 2352 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2002 | 16 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 45 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 32 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2002 | 45 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 12703 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 755 | 0.010 |
Why?
|